ACT Capital Management »

Sio Gene Therapies shares owned by ACT Capital Management

Quarter-by-quarter ownership of Sio Gene Therapies shares owned by ACT Capital Management from 13F filings

Historical chart of ACT Capital Management investment in Sio Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Sio Gene Therapies held by ACT Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sio Gene Therapies by ACT Capital Management

Quarter filed Position value Share count Share price at filing
2022-09-30 $41k 147k 0.28
2022-06-30 $53k 147k 0.36
2022-03-31 $98k 147k 0.67
2021-12-31 $239k 185k 1.29
2021-09-30 $401k 185k 2.17
2021-06-30 $506k 185k 2.74